Rubicon receives cultivation licence for Cascadia

Executive Summary

• Rubicon Organics Inc. has received its cultivation license from Health Canada for its Cascadia facility in Hope, B.C., authorizing the company to cultivate, process, and store cannabis at the site.
• The new facility adds 4,500 kilograms of annual production capacity, representing a 40% increase over existing capacity and bringing the company's total annual premium cannabis capacity to 15,500 kg.
• Operations at the Cascadia facility have commenced, with the company expecting to generate first revenue in the first half of 2026.

Key Details

• Regulatory Approval: Health Canada issued the cultivation license for the Cascadia facility, allowing for the cultivation, processing, and storage of cannabis.
• Facility Specifications: The Cascadia facility is a 47,500-square-foot, purpose-built indoor facility equipped with advanced cultivation technologies.
• Capacity Expansion:
  • Incremental capacity added: 4,500 kg annually.
  • Percentage increase: 40% over existing capacity.
  • Total annual capacity: 15,500 kg of premium cannabis.
• Timeline: Operations are currently underway; first revenue is expected in the first half of 2026.
• Facility Naming: The company announced the renaming of its facilities to reflect its West Coast culture and expanded focus:
  • Delta, B.C. facility is now named Pacifica.
  • Hope, B.C. facility is now named Cascadia.
• Strategic Impact: The additional capacity is intended to meet unmet demand for premium products in Canada and support entry into international markets.

Notable Quotes

• "The receipt of this licence is a significant step in the transformation of Rubicon Organics. This additional 40-per-cent capacity will allow Rubicon to meet currently unmet demand for our award-winning premium products in Canada and in additional markets," said Margaret Brodie, chief executive officer. "Our newly licenced Cascadia facility will also provide us with an indoor cultivation environment in which I expect certain cannabis strains will perform well, as well as additional capacity to begin addressing the international market opportunities for premium branded Rubicon product."